Snowden Capital Advisors’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $259K | Buy |
|
|||||
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $200K | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $461K | Buy |
|
|||||
|
2024
Q2 | $528K | Buy |
|
|||||
|
2024
Q1 | $651K | Buy |
|
|||||
|
2023
Q4 | $384K | Buy |
|
|||||
|
2023
Q3 | $248K | Sell |
|
|||||
|
2023
Q2 | $326K | Hold |
|
|||||
|
2023
Q1 | $263K | Sell |
|
|||||
|
2022
Q4 | $268K | Sell |
|
|||||
|
2022
Q3 | $432K | Sell |
|
|||||
|
2022
Q2 | $462K | Sell |
|
|||||
|
2022
Q1 | $531K | Sell |
|
|||||
|
2021
Q4 | $720K | Sell |
|
|||||
|
2021
Q3 | $1.53M | Buy |
|
|||||
|
2021
Q2 | $2.14M | Sell |
|
|||||
|
2021
Q1 | $2.28M | Buy |
|
|||||
|
2020
Q4 | $2.51M | Buy |
|